The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SANDPIPER: Phase III study of the PI3-kinase (PI3K) inhibitor taselisib (GDC-0032) plus fulvestrant in patients (pts) with estrogen receptor (ER)-positive, HER2-negative locally advanced or metastatic breast cancer (BC) enriched for pts with PIK3CA-mutant tumors.
 
Jose Baselga
Stock and Other Ownership Interests - Apogenix; Infinity Pharmaceuticals; Juno Therapeutics; PMV Pharma
Consulting or Advisory Role - Infinity Pharmaceuticals; Juno Therapeutics; Lilly; PMV Pharma
Travel, Accommodations, Expenses - Novartis; Roche/Genentech
 
Javier Cortes
Stock and Other Ownership Interests - MedSIR
Honoraria - Celgene; Eisai; Novartis; Roche/Genentech
Consulting or Advisory Role - Celgene; Roche/Genentech
 
Michele De Laurentiis
Honoraria - AstraZeneca; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Genomic Health; Pfizer; Roche
Research Funding - Celgene; Novartis; Pfizer; Roche
 
Veronique Dieras
Consulting or Advisory Role - Novartis; Pfizer; Roche
Speakers' Bureau - Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Novartis; Pfizer; Roche
 
Nadia Harbeck
Consulting or Advisory Role - Celgene; Novartis; Pfizer; Roche/Genentech
Speakers' Bureau - Celgene; Novartis; Pfizer; Roche/Genentech
 
Jerry Y. Hsu
Employment - Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Vivian Ng
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Frauke Schimmoller
Employment - Exelixis; Genentech
Stock and Other Ownership Interests - Exelixis; Merck; Roche; Teva
Patents, Royalties, Other Intellectual Property - Exelixis (Inst)
 
Timothy R. Wilson
Employment - Genentech
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - Genentech
 
Young-Hyuck Im
No Relationships to Disclose
 
William Jacot
Honoraria - Eisai
Consulting or Advisory Role - Pfizer
 
Ian E. Krop
Employment - Vertex (I)
Leadership - Vertex (I)
Stock and Other Ownership Interests - Vertex (I)
Consulting or Advisory Role - Amgen
Research Funding - Genentech
Travel, Accommodations, Expenses - Bayer
 
Sunil Verma
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Merck; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - Amgen; AstraZeneca; Eisai; Lilly; Novartis; Roche/Genentech